Fidia S.p.A. (BIT:FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 130.59K |
| Revenue (ttm) | 29.17M |
| Net Income (ttm) | -6.44M |
| Shares Out | 31.09M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,385,737 |
| Average Volume | 12,280,733 |
| Open | 0.0044 |
| Previous Close | 0.0042 |
| Day's Range | 0.0040 - 0.0044 |
| 52-Week Range | 0.0038 - 0.8600 |
| Beta | 0.06 |
| RSI | 29.54 |
| Earnings Date | Mar 17, 2025 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
Financial Performance
Financial StatementsNews
FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool
The U.S. Food and Drug Administration (FDA) on Friday approved Novartis AG’s (NYSE: NVS) Pluvicto for prostate cancer patients . The expanded indication, which approximately triples the number of pat...
Sanofi gets FDA nod for its hemophilia treatment
Dabur can sell its toothpaste stock with false labels till May 31: HC
Mumbai: After challenging the Food and Drug Administration's (FDA) directive to remove misleading claims from its toothpaste packaging, Dabur Ltd was .
Mass layoffs expected to begin at health agencies
Mass layoffs are expected to begin at HHS, hitting workers at agencies including the CDC, FDA and NIH. The firings come under health secretary Robert F. Kennedy Jr.
Liquidia says its request for Yutrepia final approval undergoes FDA review
Liquidia (LQDA) stock advances as its marketing application for final approval of Yutrepia undergoes FDA review. Read more here.
Why Is Milestone Pharmaceuticals Stock Plunging Today?
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) announced on Friday that its New Drug Application for CARDAMYST (etripamil) nasal spray, aimed at treating acute episodes of paroxysmal supraventricular ...
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
Recommendation is based primarily on results from the Phase 3 CheckMate -67T trial which demonstrated noninferiority in the co-primary endpoints of C avgd28 and C minss and consistent efficacy in the ...
Milestone Pharma says FDA declined to approve heart disorder therapy
FDA bars Chinese seafood companies from doing business in US after disturbing discovery found in imported clams here's what it found
Any attempt to enter the U.S. will lead to automatic detention at the border, without any physical inspection.
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (" Quantum BioPharma " or the " Company "), has reported its financial and operational resul...
Soleno Shares Are Up Today: What's Going On?
Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) extended-release tablets...
Former FDA chief counsel says she is anti-abortion, but was pushed out by GOP senator
Hilary Perkins was the Food and Drug Administration’s top attorney for less than 36 hours before she resigned. Perkins joined the Department of Justice in 2019 as a career lawyer, where she defended t...
Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug
The Japanese Ministry of Health, Labour and Welfare on Thursday approved BridgeBio Pharma, Inc. ‘s (NASDAQ: BBIO) acoramidis, under the brand name Beyonttra , for adults with transthyretin-mediated a...
Merck subcutaneous Keytruda gains FDA target date in September
Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 90 points on Thursday. The Dow traded down 0.23% to 42,358.68 while the NASDAQ fell 0.05% to 17,890.40. The S&P...
Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?
The FDA is due to make an approval decision on injectable Keytruda by mid-September. The move could bolster downtrodden Merck stock.
What's Going On With Coca-Cola Stock Today?
Coca-Cola Company (NYSE: KO) shares are trading higher on Thursday. According to Benzinga Pro , KO stock has gained over 15% in the past year. The U.S. Food and Drug Administration recalled 864 12-pa...
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America
Expecting FDA decision on marketing authorization for early-stage low risk breast cancer with endocrine therapy Positive ProSense® results were reported through 33 peer-reviewed journals and medical c...
RFK Jr. reportedly plans 10,000 job cuts in HHS with FDA, CDC, Medicare affected
Soleno Therapeutics Secures FDA Approval For Its First Commercial Drug For Rare Genetic Disorder
The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics, Inc.’s (NASDAQ: SLNO) Vykat XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for...
GSK (GSK) Gains FDA Approval for New Antibiotic, Goldman Sachs Maintains Neutral Rating
GSK (GSK) Gains FDA Approval for New Antibiotic, Goldman Sachs Maintains Neutral Rating
Soleno jumps 33% on drug approved to treat hyperphagia in Prader-Willi syndrome
FDA approves Soleno's Vykat XR for hyperphagia in Prader-Willi syndrome, driving shares up 33%. Read more here.
Mesoblast Ltd (MESO) Announces FDA Approval and U.S. ...
Mesoblast Ltd (MESO) Announces FDA Approval and U.S. Availability of Ryoncil® for Pediatric SR-aGvHD
FDA Approves Soleno Therapeutics' VYKAT XR for Prader-Willi Syndrome
FDA Approves Soleno Therapeutics' VYKAT XR for Prader-Willi Syndrome
Soleno Therapeutics Inc (SLNO) Announces FDA Approval of VYKAT XR for Prader-Willi Syndrome
Soleno Therapeutics Inc (SLNO) Announces FDA Approval of VYKAT XR for Prader-Willi Syndrome